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See related article on page 789. Your Editor solicited commentary for this provocative article,1 notso much to enter the fray concerning which method of valve-sparing aortic root replacement—Yacoub remodeling versusDavid reimplantation—is best for patients with the Marfan syn-drome (MFS), but to clarify for the readership the key differencesbetween the two procedures and how these operations have
evolved. I will also emphasize six points raised by the article.
Historically, conventional cardiovascular surgical treatment for patients with the
MFS who have aneurysm or dissection involving the ascending aorta has been
replacement of the entire aortic root and valve with a composite valve graft (CVG)
and reimplantation of the coronary artery ostia. A CVG incorporating a mechanical
valve is usually used because most of these patients are young, can safely tolerate
anticoagulation with warfarin, and do not wish to accept the risk of another
operation. Over the past 30 years, CVG has become a low risk operation and a very
durable one for patients with the MFS.2-4 On the other hand, some patients have
medical contraindications that make indefinite anticoagulation inadvisable, others
are not medically compliant enough for anticoagulation to be safe, some individuals
have lifestyles that make anticoagulation hazardous, others do not have secure
long-term access to health insurance or continuing medical care, some have an
aversion to anticoagulation, and the older patients do not need a new valve that will
last for many decades. In these relatively infrequent circumstances, the aortic root
and valve can be replaced with an allograft aortic root, a stentless porcine xenograft
aortic root, or a Dacron tube graft with a stented bioprosthesis sewn into it.4 A
Ross-Shumway procedure is contraindicated because of the aneurysmal disease and
underlying connective tissue disorder. The durability of all these various tissue
valve alternatives, however, is limited. Furthermore, the risk at reoperation is not
negligible; for example, an allograft may be densely calcified, sternal re-entry may
be perilous, the coronary ostia need to be reimplanted again, and the aortic annulus
may have scarred down excessively. Another option gaining popularity for those
wishing to avoid anticoagulation is valve-sparing aortic root replacement. But this
option is also a trade-off. How many years without warfarin will the valve last
before a second operation becomes necessary?
Valve-sparing aortic root replacement operations can be subdivided into two
general families: (1) the Yacoub “remodeling” procedure used since 19795-9 and (2)
the David “reimplantation” procedure performed since 1988.1,10-14 The paper under
discussion in this issue1 of the Journal is focused solely on 105 patients with the
MFS classified strictly according to the Ghent criteria: 44 patients received a CVG
and 61 underwent valve-sparing aortic root replacement. What is the difference
between the remodeling and the reimplantation methods of valve-sparing aortic root
replacement? The easiest way to distinguish between them is whether the procedure
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employs 2 aortic suture lines (Yacoub remodeling tech-
nique) or 3 (David reimplantation technique). There are
variations of the remodeling procedure,15-19 but they all rely
on sewing the scalloped graft to residual aortic sinus tissue
around the aortic cusps and commissures proximally. One
putative advantage of the remodeling approach is that the
graft billows, thereby mimicking the natural sinuses of
Valsalva. This allows more natural leaflet motion9 and
should theoretically reduce cusp closing stresses and
thereby enhance long-term valve durability.20,21 Conversely,
there are two drawbacks of any remodeling procedure: (1)
absence of fixation of the aortic annulus (more properly
called the “ventriculo-aortic junction,” which is coronet
shaped and not planar), which can predispose to postoper-
ative annular dilatation and recurrent aortic regurgitation
(AR); and (2) two (instead of one) exposed aortic suture
lines, which can predispose to bleeding. Of course, both
techniques require reimplantation of the coronary ostia
(preferably using full-thickness Carrel buttons), which less
commonly can also be sites of bleeding. When Sir Magdi
discussed the current paper1 as well as David and Feindel’s
paper12 presented at the 2000 annual meeting of The Amer-
ican Association for Thoracic Surgery, he mentioned subtle
modifications in his technique over the years, including
picking the proper graft size, cutting narrower and shorter
scallops in the graft, and reattaching the commissures up
inside the graft higher than the apex of the scallops. Other
adaptations include those reported by Dion’s group17 in 27
patients (9 with the MFS), Svensson’s semi-inclusion hy-
brid technique18 used in 13 patients (not stated was how
many had the MFS), which relies on side-to-side anastomo-
ses that may not necessarily be full-thickness suture bites,
and Hvass’ method19 wherein the lower scalloped Dacron
graft is placed inside the retained native sinuses (n  5).
Scha¨fers’ unit in Homburg has a relatively large overall
experience (n  99) predominately with the Yacoub ap-
proach,22-24 but had only 5 patients with the MFS in their
latest report.24 Even more confusing, David himself also
used two remodeling techniques in the past—which I call
the “T. David-II” (classic Yacoub remodeling) and the “T.
David-III” (remodeling with an external synthetic strip
added between the left and right mitral fibrous trigones [the
fibrous portion of the left ventricular outflow tract] as an
external narrowing annuloplasty).1,12,13
What is the rationale behind the various modifications of
the reimplantation technique and what do they strive to
accomplish? Number one, all reimplantation methods firmly
anchor the aortic graft proximally at the ventriculo-aortic
junction below the leaflets with the commissures sewn
inside the Dacron graft. Although David objects to my
labeling, I have resorted to numbering his various valve-
sparing aortic root operations because Tirone’s technique
changes frequently: A “T. David-I” is his original reimplan-
tation procedure using a cylindrical tube graft; the “T.
David-II” and “T. David-III” are variations of Yacoub’s
remodeling procedure (see above); a “T. David-IV” is re-
implantation using a 4-mm larger graft size with plication of
the graft circumferentially at the sinotubular junction above
the tops of the commissures; and a “T. David-V” (used by
David and me since May 2001) is reimplantation using an
even larger graft size (d  6-8 mm), which is “necked
down” at both the bottom and the top ends to create graft
pseudosinuses (Figure 1). The “T. David-V” technique
gives the surgeon unlimited flexibility in terms of the rela-
tive sizes that he or she makes the annulus, neosinuses, and
sinotubular ridge, as well as the “height” of the neosinuses,
which are quite prominent echocardiographically. Since
David’s entire valve-sparing experience (1988-2001) in 61
MFS patients is reported in the current article,1 one assumes
that all 5 procedures were used: reimplantation in 39 (“T.
David-I, -IV, or -V”) and remodeling in 22 (“T. David-II or
-III”). Other modifications of reimplantation valve-sparing
root replacement include the Cochran procedure20 intro-
duced in 1995 (n  10, 5 with the MFS), which is note-
worthy because it creates pseudosinuses in the graft as
prompted by the mathematical modeling studies of Coch-
ran,20 Grande-Allen,21 and their associates. An innovative
modification by Mohr’s group25 in 13 patients (4 with the
MFS) reduces the size of the natural sinuses of Valsalva,
and they are then sewn inside of graft in toto as one circular
transverse suture line, instead of the usual up and down
around the scalloped commissures. Moritz started in Vienna
using the classic “T. David-I” technique,26 but since moving
to Frankfurt he has modified the technique to use an over-
sized graft and plicate the bottom (or annular) end of the
graft in an attempt to create neosinuses.* This is different
from the “T. David-IV” procedure, in which only the distal
end (or sinotubular junction) of the graft is necked down.
Moritz’s group demonstrated more physiologic leaflet open-
ing and closing dynamics in 21 patients who underwent
their modified David valve-sparing root replacement com-
pared with 25 others who had a “T. David-I,” but only 3
patients had the MFS.* The Hannover group, initially under
the direction of Professor Hans Borst and subsequently Axel
Haverich, has popularized the original “T. David-I” reim-
plantation concept, which they first started using in
1993.27-31 In their most recent publication of 101 patients,
they analyzed 75 individuals who had been followed up for
longer than 1 year; of these, 22 had the MFS.28 MFS was not
a predictor of postoperative AR. Recently, De Paulis and
associates32,33 introduced a new “sinus graft” that includes a
larger size, compliant graft segment (“skirt”) above a nar-
rower, short “collar”; De Paulis’s group34 originally used
*Aybek T, Wo¨hleke T, Sotiriou M, Miskovic A, Simon A, Doss M, et al.
Alteration of opening and closing cusp dynamics after aortic valve sparing
operations. Unpublished data.
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this graft for Yacoub remodeling but soon switched to the
David reimplantation method; 5 of their 16 patients had the
MFS. Changing to the reimplantation technique is not sur-
prising given that an earlier paper on Yacoub remodeling
from this same unit35 (n 36, 4 with the MFS) reported that
3 of 4 patients with the MFS had required reoperation
within 3 years. This newly available commercial graft is an
attractive concept. Modifying the fabrication of the graft
using customized teardrop-shaped sinuses of individual
compliance was devised by Thubrikar and Robicsek36-38 and
can be applied either to remodeling or to reimplantation.
Over the past decade, some surgeons, Tirone David and
I included, switched temporarily to the Yacoub remodeling
technique because it is quicker, saves one suture line, and
requires much less extensive dissection and mobilization of
the aortic root; however, most of us soon recognized that it
was not as predictable as the reimplantation technique,
especially in patients with the MFS. On the other hand, rare
Figure 1. A, Operative photograph of “T. David-V” reimplantation valve-sparing aortic root replacement in a patient
with the MFS illustrating how the over-sized 32-mm woven double velour Hemashield graft (Medi-Tech, Boston
Scientific Corp, Natick, Mass) is necked down proximally to fit a 25-mm valve sizer using interrupted 5-0 plication
sutures (red arrows). B, The valve is sewn inside the graft before the distal end of the graft is plicated. Using a
larger graft facilitates exposure and eliminates buckling and crowding of the aortic root tissue when sewing the
scalloped upper valve suture line compared with when a smaller, cylindrical tube graft is used, as in the “T.
David-I” procedure. C, Completed operation showing the reimplanted right coronary artery button and interrupted
5-0 braided polyester plication sutures (some of which are denoted by the white arrows) at the top of the
commissures to neck down the sinotubular junction of the graft.
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patients have the aortic annulus so deeply “countersunk”
that adequate mobilization of the base of the aortic root to
place the bottom row of sutures in the subannular plane for
valve reimplantation may require skeletonization of the
tricuspid annulus and the central fibrous body of the heart;
in such circumstances, reverting either to a remodeling
procedure or a CVG is prudent. Patients with an extremely
dilated aortic annulus (29-31 mm) and/or abnormal aortic
leaflets should probably receive a CVG because one cannot
be confident about long-term valve durability. On the other
hand, individuals with prolapse (usually the noncoronary
cusp) or with stretched, elongated aortic valve cusps can
have successful repair by reducing the length of the cusp
free margin with a 5-0 or 6-0 braided polyester plication
suture, which elevates the level of cusp coaptation higher up
into the graft.4,24 David uses a running 6-0 polytetrafluoro-
ethylene* suture for this step. Indeed, one actually creates
relative prolapse de facto in making the aortic root consid-
erably smaller using either technique, which underscores
not selecting too small a graft. Haverich’s group has re-
cently pointed out the importance of recreating a higher
plane of cusp coaptation to enhance valve competence.28
As surgeons have gained more experience, valve-sparing
aortic root replacement has been applied to other patient
substrates, including those with bicuspid aortic valves,1,7,22
acute type A aortic dissection,1,7,23,27,39,40 a failing (full root)
Ross procedure secondary to dilatation of the sinotubular
junction,41,42 and patients with a chronic type A dissection
after previous supracoronary tube graft repair.31 While the
short-term results using either remodeling7,23,39 or reimplan-
tation1,27 for acute aortic dissection have generally been
satisfactory in terms of valve durability, long-term survival
has not been optimal.7 The Hannover group, however, re-
cently cautioned that 3 of 8 patients with acute dissection
who received a Yacoub remodeling procedure required re-
operation for AR within 4 years.40 The David reimplanta-
tion concept is better for acute aortic dissection because it is
more hemostatic—the only suture lines that can bleed are
the coronary buttons and the distal aortic anastomosis. In
fact, David’s current article states that the take-back for
bleeding rates was 3% for reimplantation versus 18% for
remodeling in patients with the MFS (and only 15% of these
patients had an acute aortic dissection).1
Issues in the Current Article
This article1 deserves amplification regarding six points.
First, it is remarkable that no patient having a valve-sparing
procedure required reoperation for AR in the absence of
endocarditis. The 8-year results after valve reimplantation
are excellent, despite the theoretical shortcoming that no
graft pseudosinuses were created in their earlier (“T. David-
I”) experience.1,29,30 Second, only the reimplantation proce-
dure has been performed in MFS patients by this group
since 1999. This change is probably based on both practical
considerations (more bleeding with the Yacoub procedure)
and long-term concerns about valve durability after remod-
eling. Third, the comparisons between the valve-sparing and
the CVG groups should be interpreted with circumspection,
as the CVG group was quite different and had longer
follow-up. Fourth, 18 of the 44 CVG patients had biologic
valves used, and 3 of these tissue valves ultimately failed
and necessitated reoperation; thus, the actuarial curves in
the graphs depicting freedom from reoperation or valve-
related morbidity and mortality are exaggerated. The au-
thors do, however, report in the text the freedom rates for
CVG patients who received a mechanical valve, which are
higher. Fifth, while it is apparent that the MFS patients who
underwent a Yacoub-type of valve-sparing aortic root re-
placement experienced over time a 5% increase in aortic
annulus diameter and 17% increase in neo-aortic sinus
diameter (see Table 3), this was due to progressive dilata-
tion in only 10 of the 22 patients who underwent remodel-
ing.1 Annuloplasty (“T. David-III”) had no demonstrable
effect on late dilatation. Why did some Yacoub patients
have dilatation and others not? Was this a function of the
initial annular or aneurysm size? Did it have anything to do
with individual pathologic conditions, for example, acute
aortic dissection? It will take analysis of larger numbers of
patients to answer these questions, but such insight could
lead to more refined criteria for specifically when to avoid a
remodeling procedure. Sixth, children were excluded from
this report (with the exception of one 12-year-old boy)
because pediatric patients are not operated on at the Toronto
General Hospital.1 Treating children with the MFS and
ascending aortic disease introduces a whole different set of
problems. Even though an adult-sized CVG can usually be
used in a child over the age of 10 years, indefinite antico-
agulation during the adolescent years is challenging and not
without complications. Allograft aortic root replacement
has been discouraging because of very limited durability,
but in younger children a David-type of reimplantation
valve-sparing procedure may result in the child outgrowing
the (fixed) aortic annulus and requiring reoperation for
stenosis. In an attempt to find something superior to the use
of allografts, Cameron has performed 80 valve-sparing aor-
tic root replacements at Johns Hopkins; approximately 40 of
which were in children or young adults (about one-half of
these had the MFS). Only one of the MFS patients has
required reoperation so far, but worrisome annular dilata-
tion and AR have developed postoperatively in many pa-
tients (personal communication, Duke E. Cameron, MD,
2002). Unsatisfactory results with the Yacoub procedure in
children have also been reported from the Hoˆpital Necker-
Enfants in Paris.43
*Gore-Tex suture; registered trade mark of W. L. Gore & Associates, Inc,
Flagstaff, Ariz.
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The Bottom Line
We now know that either type of valve-sparing aortic root
replacement is safe, reproducible, and associated with rea-
sonable 5- to 10-year results for selected patients with the
MFS, at least in certain institutions. While satisfactory, the
outcomes are not perfect. Notwithstanding the excellent
survival statistics in the current report, 25% of the MFS
patients undergoing valve-sparing aortic root replacement
had 3 or 4 AR at 10 years (Figure 4)1; further, inspec-
tion of Figure 5 suggests that the late actuarial estimate of
freedom from AR was lower (albeit insignificantly so due to
the small numbers of patients remaining at risk) if the
Yacoub technique was used (71%  21% free for remod-
eling versus 96%  4% for reimplantation at 8 years). The
latest report (average follow-up 36 months) from the Han-
nover group28 reported that 8 of 75 patients (22 had the
MFS) had 2 or more AR beyond 1 year, and 3 had already
required reoperation. In Yacoub’s experience using exclu-
sively the remodeling technique in 82 patients with the
MFS, 17% had required reoperation by 10 years, and an
additional 22% had moderate AR at the time of last fol-
low-up (mean  5.5 years, median  3 years).8
What remains unknown is the truly long-term results in
larger numbers of patients with the MFS and whether the
overall incidence of all valve-related and aorta-related com-
plications will be lower than that after conventional CVG
with a mechanical prosthetic valve. To this end, the Na-
tional Marfan’s Foundation is sponsoring a prospective
multicenter registry investigation of both types of valve-
sparing aortic root replacement procedures in patients with
the MFS. Participating centers from around the world have
already committed to this project, which they hope will be
launched in 2003. Clinical and operative information, as
well as serial echocardiographic, computed tomographic,
and magnetic resonance imaging data, will be collected and
analyzed. Only when the long-term results of such studies
are compiled will we know with certainty which type of
valve-sparing operation is more durable, how “generaliz-
able” the clinical results really are, and whether overall
outcome is superior to that after CVG.
In the interim, with all due respect to Sir Magdi’s beliefs
and vast experience (he truly is a master surgeon), I believe
we should be conservative for valve-sparing aortic root
replacement in patients with the MFS, which is the most
demanding patient substrate: a reimplantation-type proce-
dure that reliably prevents future dilatation of the aortic
annulus is the most prudent choice based on the data avail-
able at this time. Seasoned surgical judgment and careful
patient selection are key in deciding whether valve-sparing
root replacement is the best option. It also is implicit that a
patient who chooses valve-sparing root replacement be well
informed and understand that a second operation may be
necessary. Patients should seek out a cardiovascular sur-
geon who has considerable personal experience with valve-
sparing aortic root replacement, because the initial learning
curve can be steep. These procedures are unforgiving in
terms of small technical errors and, at this time, truly are
based more on 3-dimensional geometric thinking and “art”
than they are on science.
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